New York, United States
Ascertain is positioning itself at the forefront of the intersection between healthcare and artificial intelligence. Founded in 2022, this U.S.-based entity emerges as a powerful collaboration between Northwell Health and Aegis Ventures, focusing on developing revolutionary AI solutions to tackle significant issues in healthcare such as quality, access, and equity.
The company seamlessly unites a diverse team comprising clinicians, engineers, and business leaders, intent on leveraging AI to enhance healthcare delivery across communities. By capitalizing on Northwell Health’s extensive datasets and insights, Ascertain aims to launch AI-driven healthcare solutions at scale, addressing some of the industry's most persistent challenges.
Recent activities indicate strong financial momentum, underscored by a $7.38M venture round investment dated March 28, 2024. Ascertain’s focus on industry-altering technologies makes it an attractive contender for investors looking to drive sizeable impact in the AI and Healthcare sectors.
